(Q40406797)

20 September 2017

Concomitant RASSF1A hypermethylation and KRAS/BRAF mutations occur preferentially in MSI sporadic colorectal cancer (English)

1 reference

20 September 2017

1 reference

1 reference

1

1 reference

20 September 2017

2

1 reference

20 September 2017

4

1 reference

20 September 2017

8

1 reference

20 September 2017

Enric Domingo

3

1 reference

20 September 2017

Robert M W Hofstra

5

1 reference

20 September 2017

Richard Hamelin

6

1 reference

20 September 2017

Hiroyuki Yamamoto

7

1 reference

20 September 2017

Simo Schwartz

9

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 November 2005

1 reference

20 September 2017

5

1 reference

inferred from page(s)

published in

Oncogene

1 reference

20 September 2017

24

1 reference

20 September 2017

51

1 reference

20 September 2017

7630-7634

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1208906

20 September 2017

0 references

cites work

RAF/RAS oncogenes and mismatch-repair status

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208906

Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208906

Frequent ki-ras mutations in gastric tumors of the MSI phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208906

Activated BRAF targets proximal colon tumors with mismatch repair deficiency and MLH1 inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208906

7 January 2021

BRAF mutations characterize colon but not gastric cancer with mismatch repair deficiency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208906

7 January 2021

The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208906

7 January 2021

Testing guidelines for hereditary non-polyposis colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208906

7 January 2021

K-ras mutations and RASSF1A promoter methylation in colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208906

7 January 2021

Elucidation of binding determinants and functional consequences of Ras/Raf-cysteine-rich domain interactions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208906

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1208906

1 reference

Dimensions Publication ID

20 September 2017

0 references

1 reference